# CGON (CG Oncology, Inc.) - SEC EDGAR Financial Statements

> CG Oncology, Inc. reported $6.17M in revenue and a net loss of $237.5M for the trailing twelve months ended September 30, 2026 (down 3.7% year over year), with a -4293.5% operating margin.

- Canonical: https://convexityos.com/fundamentals/CGON
- Markdown: https://convexityos.com/fundamentals/CGON.md
- SEC CIK: 0001991792
- Reporting currency: USD
- Latest filing period: September 30, 2026
- Last synced: Nov 20, 2026, 05:13 UTC
- Primary source: [SEC EDGAR](https://www.sec.gov/cgi-bin/browse-edgar?action=getcompany&CIK=0001991792&type=&dateb=&owner=include&count=40)

## Key Financial Metrics

| Metric | Period | Value | Notes |
| --- | --- | --- | --- |
| Revenue | TTM | $6.17M | -3.7% YoY |
| Operating Income | TTM | -$264.7M | -4293.5% margin |
| Net Income | TTM | -$237.5M | -3851.1% net margin |
| Diluted EPS | TTM | -$2.67 | Split-adjusted |
| Free Cash Flow | TTM | -$189.2M | -3068.0% FCF margin |
| Cash & ST Investments | Sep 30, 2026 | $984.5M | Total debt: $9.24M |

## Income Statement

### Income Statement (Annual)

| Line Item | FY 2025 | FY 2024 | FY 2023 |
| --- | --- | --- | --- |
| **Revenue** | $4.04M | $1.14M | $204K |
| Research & Development | $116.6M | $82.10M | $45.75M |
| Total Operating Expenses | -- | $115.8M | $55.65M |
| **Operating Income** | -$190.8M | -$114.7M | -$55.45M |
| **EBITDA** | -$189.3M | -$114.6M | -$55.43M |
| Interest Income | $29.93M | $26.62M | $6.90M |
| Income Tax Expense | -$270K | $1.0K | $1.0K |
| **Net Income** | -$161.0M | -$88.04M | -$48.61M |
| Basic EPS | -$2.08 | -$1.41 | -$15.65 |
| **Diluted EPS** | -$2.08 | -$1.41 | -$15.65 |
| Basic Shares Outstanding | 77.3M | 62.5M | 4.3M |
| Diluted Shares Outstanding | 77.3M | 62.5M | 4.3M |

### Income Statement (Quarterly)

| Line Item | Sep 2026 | Jun 2026 | Mar 2026 | Dec 2025 | Sep 2025 | Jun 2025 | Mar 2025 | Dec 2024 |
| --- | --- | --- | --- | --- | --- | --- | --- | --- |
| **Revenue** | $1.60M | $1.16M | $1.08M | $2.32M | $1.67M | $0 | $52K | $456K |
| Cost of Revenue | $2.67M | -- | -- | -- | $1.58M | -- | -- | -- |
| **Gross Profit** | -$1.06M | -- | -- | -- | $89K | -- | -- | -- |
| Research & Development | $39.22M | $54.66M | $43.73M | $29.96M | $27.88M | $31.33M | $27.47M | $26.80M |
| Total Operating Expenses | -- | -- | -- | -- | -- | $48.74M | $42.26M | $38.51M |
| **Operating Income** | -$63.25M | -$86.40M | -$66.39M | -$48.70M | -$51.13M | -$48.74M | -$42.20M | -$38.05M |
| **EBITDA** | -$62.09M | -$85.55M | -$65.55M | -$47.85M | -$50.71M | -$48.59M | -$42.18M | -$38.05M |
| Interest Income | $6.42M | $7.33M | $6.29M | $7.44M | $7.42M | $7.32M | $7.75M | $6.25M |
| **Net Income** | -$56.89M | -$79.06M | -$60.20M | -$41.31M | -$43.81M | -$41.43M | -$34.45M | -$31.80M |
| Basic EPS | -$0.64 | -$0.90 | -$0.71 | -- | -$0.57 | -$0.54 | -$0.45 | -- |
| **Diluted EPS** | -$0.64 | -$0.90 | -$0.71 | -- | -$0.57 | -$0.54 | -$0.45 | -- |
| Basic Shares Outstanding | 88.9M | 88.2M | 84.5M | -- | 76.7M | 76.2M | 76.2M | -- |
| Diluted Shares Outstanding | 88.9M | 88.2M | 84.5M | -- | 76.7M | 76.2M | 76.2M | -- |

## Balance Sheet

### Balance Sheet (Annual)

| Line Item | FY 2025 | FY 2024 | FY 2023 |
| --- | --- | --- | --- |
| Cash & Cash Equivalents | $32.49M | $257.1M | $8.27M |
| Short-Term Investments | $709.7M | $484.9M | $179.4M |
| **Cash & Short-Term Investments** | $742.2M | $742.0M | $187.7M |
| Accounts Receivable, Net | $688K | $0 | -- |
| Inventory | $1.56M | $0 | -- |
| **Total Current Assets** | $759.5M | $754.2M | $194.1M |
| Property, Plant & Equipment, Net | $15.60M | $272K | $69K |
| Goodwill | $10.30M | $0 | -- |
| Intangible Assets | $575K | $0 | -- |
| Other Non-Current Assets | $1.68M | $94K | $19K |
| **Total Non-Current Assets** | $32.12M | $587K | $5.18M |
| **Total Assets** | $791.6M | $754.8M | $199.3M |
| Accounts Payable | $5.71M | $6.52M | $3.24M |
| Deferred Revenue (Current) | $286K | -- | -- |
| **Total Current Liabilities** | $30.84M | $21.37M | $14.25M |
| Long-Term Debt | $3.00M | $0 | -- |
| Other Non-Current Liabilities | $1.74M | $0 | -- |
| **Total Non-Current Liabilities** | $8.15M | $52K | $257K |
| **Total Liabilities** | $38.99M | $21.42M | $14.51M |
| **Total Debt (incl. Leases)** | $7.02M | $238K | $461K |
| Common Stock | $8.0K | $8.0K | -- |
| Retained Earnings | -$379.0M | -$218.0M | -$129.9M |
| **Total Stockholders' Equity** | $752.6M | $733.4M | -$123.1M |
| Total Equity | $752.6M | $733.4M | -$123.1M |

### Balance Sheet (Quarterly)

| Line Item | Sep 2026 | Jun 2026 | Mar 2026 | Dec 2025 | Sep 2025 | Jun 2025 | Mar 2025 | Dec 2024 |
| --- | --- | --- | --- | --- | --- | --- | --- | --- |
| Cash & Cash Equivalents | $28.25M | $19.64M | $33.70M | $32.49M | $45.15M | $14.62M | $41.47M | $257.1M |
| Short-Term Investments | $956.2M | $1.01B | $1.04B | $709.7M | $635.1M | $646.4M | $647.0M | $484.9M |
| **Cash & Short-Term Investments** | $984.5M | $1.03B | $1.08B | $742.2M | $680.3M | $661.1M | $688.4M | $742.0M |
| Accounts Receivable, Net | $666K | $417K | $1.27M | $688K | $515K | -- | -- | $0 |
| Inventory | $1.17M | $1.00M | $1.49M | $1.56M | $1.50M | -- | -- | $0 |
| **Total Current Assets** | $1.01B | $1.05B | $1.10B | $759.5M | $695.8M | $673.0M | $701.2M | $754.2M |
| Property, Plant & Equipment, Net | $14.93M | $14.71M | $15.07M | $15.60M | $15.33M | $253K | $264K | $272K |
| Goodwill | $10.30M | $10.30M | $10.30M | $10.30M | $12.80M | -- | -- | $0 |
| Intangible Assets | $530K | $545K | $560K | $575K | $1.67M | -- | -- | $0 |
| Other Non-Current Assets | $6.92M | $4.73M | $2.68M | $1.68M | $114K | $522K | $516K | $94K |
| **Total Non-Current Assets** | $38.94M | $36.01M | $33.12M | $32.12M | $34.12M | $28.41M | $26.99M | $587K |
| **Total Assets** | $1.05B | $1.09B | $1.14B | $791.6M | $729.9M | $701.4M | $728.2M | $754.8M |
| Accounts Payable | $9.77M | $12.73M | $8.24M | $5.71M | $9.19M | $7.12M | $6.73M | $6.52M |
| Deferred Revenue (Current) | $29K | -- | -- | $286K | -- | -- | -- | -- |
| **Total Current Liabilities** | $46.43M | $47.24M | $35.22M | $30.84M | $30.53M | $30.38M | $22.64M | $21.37M |
| Long-Term Debt | $3.00M | $3.00M | $3.00M | $3.00M | $3.00M | -- | -- | $0 |
| Other Non-Current Liabilities | $855K | $1.16M | $1.45M | $1.74M | $3.80M | -- | -- | $0 |
| **Total Non-Current Liabilities** | $9.27M | $9.30M | $8.27M | $8.15M | $11.74M | $706K | $781K | $52K |
| **Total Liabilities** | $55.70M | $56.54M | $43.48M | $38.99M | $42.27M | $31.09M | $23.42M | $21.42M |
| **Total Debt (incl. Leases)** | $9.24M | $8.82M | $7.58M | $7.02M | $7.24M | $994K | $1.04M | $238K |
| Common Stock | $9.0K | $9.0K | $9.0K | $8.0K | $8.0K | $8.0K | $8.0K | $8.0K |
| Retained Earnings | -$575.1M | -$518.2M | -$439.2M | -$379.0M | -$337.7M | -$293.9M | -$252.4M | -$218.0M |
| **Total Stockholders' Equity** | $991.0M | $1.03B | $1.09B | $752.6M | $687.6M | $670.4M | $704.8M | $733.4M |
| Total Equity | $991.0M | $1.03B | $1.09B | $752.6M | $687.6M | $670.4M | $704.8M | $733.4M |

## Cash Flow Statement

### Cash Flow Statement (Annual)

| Line Item | FY 2025 | FY 2024 | FY 2023 |
| --- | --- | --- | --- |
| Net Income | -$161.0M | -$88.04M | -$48.61M |
| Depreciation & Amortization | $1.45M | $32K | $17K |
| Stock-Based Compensation | $26.68M | $11.40M | $1.53M |
| Change in Receivables | -$320K | -- | -- |
| Change in Inventory | -$444K | -- | -- |
| Change in Payables | -$1.64M | $3.27M | $2.01M |
| **Operating Cash Flow** | -$132.3M | -$78.71M | -$45.68M |
| Capital Expenditure | -$134K | -$234K | -- |
| **Free Cash Flow** | -$132.5M | -$78.95M | -- |
| Acquisitions, Net | -$21.97M | -- | -- |
| Purchases of Investments | -$1.07B | -$1.05B | -$517.6M |
| Sales & Maturities of Investments | $844.1M | $745.4M | $396.4M |
| **Investing Cash Flow** | -$245.8M | -$300.8M | -$121.2M |
| Common Stock Issued | $147.4M | $223.1M | -- |
| **Financing Cash Flow** | $153.6M | $628.3M | $87.00M |
| **Net Change in Cash** | -$224.6M | $248.8M | -$79.88M |

### Cash Flow Statement (Quarterly)

| Line Item | Sep 2026 | Jun 2026 | Mar 2026 | Dec 2025 | Sep 2025 | Jun 2025 | Mar 2025 | Dec 2024 |
| --- | --- | --- | --- | --- | --- | --- | --- | --- |
| Net Income | -$56.89M | -$79.06M | -$60.20M | -$41.31M | -$43.81M | -$41.43M | -$34.45M | -$31.80M |
| Depreciation & Amortization | $1.16M | $850K | $841K | $849K | $416K | $156K | $24K | $0 |
| Stock-Based Compensation | $8.46M | $14.33M | $6.47M | $7.19M | $7.33M | $7.01M | $5.15M | $4.99M |
| Change in Receivables | -$249K | $858K | -$587K | -- | -- | -- | -- | -- |
| Change in Inventory | -$162K | $490K | $72K | -- | -- | -- | -- | -- |
| Change in Payables | -$2.96M | $4.49M | $2.52M | -$3.48M | $1.23M | $394K | $214K | $2.44M |
| **Operating Cash Flow** | -$47.71M | -$46.41M | -$56.94M | -$36.22M | -$38.89M | -$27.96M | -$29.28M | -$20.66M |
| Capital Expenditure | -$1.11M | -$468K | -$304K | -$7.0K | -$97K | -$14K | -$16K | -$209K |
| **Free Cash Flow** | -$48.82M | -$46.88M | -$57.25M | -$36.22M | -$38.99M | -$27.97M | -$29.29M | -$20.87M |
| Purchases of Investments | -- | -$196.0M | -$587.4M | -$297.7M | -$240.3M | -$168.0M | -$361.9M | -- |
| Sales & Maturities of Investments | $169.7M | $226.9M | $252.9M | $222.2M | $251.4M | $170.4M | $200.1M | -- |
| **Investing Cash Flow** | $46.03M | $30.43M | -$334.8M | -$75.50M | $15.04M | $1.41M | -$186.8M | $10.90M |
| Common Stock Issued | $0 | $0 | $391.6M | -- | -- | -- | -- | -- |
| **Financing Cash Flow** | $10.28M | $1.92M | $393.0M | $99.07M | $54.37M | -$296K | $450K | $223.4M |
| **Net Change in Cash** | $8.61M | -$14.06M | $1.21M | -$12.65M | $30.52M | -$26.85M | -$215.6M | $213.7M |

## Profitability Ratios & YoY Growth

### Profitability Ratios & YoY Growth (Annual)

| Line Item | FY 2025 | FY 2024 | FY 2023 |
| --- | --- | --- | --- |
| **Operating Margin** | -4722.1% | -10067.3% | -27180.9% |
| **Net Profit Margin** | -3985.0% | -7729.5% | -23827.0% |
| Return on Equity (ROE) | -21.4% | -12.0% | -- |
| Return on Assets (ROA) | -20.3% | -11.7% | -24.4% |
| Current Ratio | 24.63x | 35.30x | 13.62x |
| Quick Ratio | 24.58x | 35.30x | 13.17x |
| Debt to Equity | 0.01x | 0.00x | -- |
| **Revenue Growth (YoY)** | +254.7% | +458.3% | -- |

### Profitability Ratios & YoY Growth (Quarterly)

| Line Item | Sep 2026 | Jun 2026 | Mar 2026 | Dec 2025 | Sep 2025 | Jun 2025 | Mar 2025 | Dec 2024 |
| --- | --- | --- | --- | --- | --- | --- | --- | --- |
| **Operating Margin** | -4293.5% | -4056.2% | -4239.0% | -4722.1% | -8285.3% | -28546.1% | -20302.3% | -10067.3% |
| **Net Profit Margin** | -3851.1% | -3602.7% | -3682.6% | -3985.0% | -6968.0% | -23245.2% | -15945.2% | -7729.5% |
| Return on Equity (ROE) | -24.0% | -21.8% | -17.1% | -21.4% | -22.0% | -19.1% | -15.0% | -12.0% |
| Return on Assets (ROA) | -22.7% | -20.7% | -16.4% | -20.3% | -20.8% | -18.3% | -14.5% | -11.7% |
| Current Ratio | 21.70x | 22.22x | 31.30x | 24.63x | 22.79x | 22.15x | 30.97x | 35.30x |
| Quick Ratio | 21.68x | 22.20x | 31.25x | 24.58x | 22.74x | 21.76x | 30.41x | 35.30x |
| Debt to Equity | 0.01x | 0.01x | 0.01x | 0.01x | 0.01x | 0.00x | 0.00x | 0.00x |
| **Revenue Growth (YoY)** | -3.7% | -- | +1982.7% | +409.2% | +3774.4% | -100.0% | -90.2% | +45500.0% |
| Gross Profit Growth (YoY) | -1296.6% | -- | -- | -- | -- | -- | -- | -- |

## Related Companies

[AMZN (Amazon.com, Inc.)](https://convexityos.com/fundamentals/AMZN), [WMT (Walmart Inc.)](https://convexityos.com/fundamentals/WMT), [AAPL (Apple Inc.)](https://convexityos.com/fundamentals/AAPL), [GOOG (Alphabet Inc.)](https://convexityos.com/fundamentals/GOOG), [UNH (UnitedHealth Group Incorporated)](https://convexityos.com/fundamentals/UNH), [CVS (CVS HEALTH Corp)](https://convexityos.com/fundamentals/CVS), [MCK (McKESSON CORPORATION)](https://convexityos.com/fundamentals/MCK), [BRK-A (Berkshire Hathaway Inc.)](https://convexityos.com/fundamentals/BRK-A)

---

## About Convexity

Published by [Convexity](https://convexityos.com/), a primary-source financial intelligence terminal built on SEC EDGAR filings, XBRL financial statements, options, macro data, and cited AI research. Free tier with no card and published prices at https://convexityos.com/pricing; Streamable HTTP MCP server at https://convexityos.com/mcp; full site index at https://convexityos.com/llms.txt.
